The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Newborn and Prenatal Genetic Testing Market Research Report 2024
Synopsis
Newborn and prenatal genetic testing is to judge the underlying genetic disease of the newborn and fetus.
The global Newborn and Prenatal Genetic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Due to the increased prevalence of genetic diseases and chromosomal abnormalities, the need for early screening for prenatal and newborn defects has increased. According to the Centers for Disease Control and Prevention (CDC), birth defects occur in about 3% of the total number of live births worldwide, leading to infant death.
This report aims to provide a comprehensive presentation of the global market for Newborn and Prenatal Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn and Prenatal Genetic Testing.
Report Scope
The Newborn and Prenatal Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Newborn and Prenatal Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn and Prenatal Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perkin Elmer
Verinata Health
Sequenom, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Natera, Inc.
Illumina, Inc.
Ariosa Diagnostics
BGI
CapitalBio MedLab
Segment by Type
PCR
FISH
aCGH
NIPT
MSS
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn and Prenatal Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Newborn and prenatal genetic testing is to judge the underlying genetic disease of the newborn and fetus.
The global Newborn and Prenatal Genetic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Due to the increased prevalence of genetic diseases and chromosomal abnormalities, the need for early screening for prenatal and newborn defects has increased. According to the Centers for Disease Control and Prevention (CDC), birth defects occur in about 3% of the total number of live births worldwide, leading to infant death.
This report aims to provide a comprehensive presentation of the global market for Newborn and Prenatal Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn and Prenatal Genetic Testing.
Report Scope
The Newborn and Prenatal Genetic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Newborn and Prenatal Genetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn and Prenatal Genetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perkin Elmer
Verinata Health
Sequenom, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Natera, Inc.
Illumina, Inc.
Ariosa Diagnostics
BGI
CapitalBio MedLab
Segment by Type
PCR
FISH
aCGH
NIPT
MSS
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn and Prenatal Genetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn and Prenatal Genetic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 FISH
1.2.4 aCGH
1.2.5 NIPT
1.2.6 MSS
1.3 Market by Application
1.3.1 Global Newborn and Prenatal Genetic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn and Prenatal Genetic Testing Market Perspective (2019-2030)
2.2 Newborn and Prenatal Genetic Testing Growth Trends by Region
2.2.1 Global Newborn and Prenatal Genetic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Newborn and Prenatal Genetic Testing Historic Market Size by Region (2019-2024)
2.2.3 Newborn and Prenatal Genetic Testing Forecasted Market Size by Region (2025-2030)
2.3 Newborn and Prenatal Genetic Testing Market Dynamics
2.3.1 Newborn and Prenatal Genetic Testing Industry Trends
2.3.2 Newborn and Prenatal Genetic Testing Market Drivers
2.3.3 Newborn and Prenatal Genetic Testing Market Challenges
2.3.4 Newborn and Prenatal Genetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn and Prenatal Genetic Testing Players by Revenue
3.1.1 Global Top Newborn and Prenatal Genetic Testing Players by Revenue (2019-2024)
3.1.2 Global Newborn and Prenatal Genetic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Newborn and Prenatal Genetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Newborn and Prenatal Genetic Testing Revenue
3.4 Global Newborn and Prenatal Genetic Testing Market Concentration Ratio
3.4.1 Global Newborn and Prenatal Genetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn and Prenatal Genetic Testing Revenue in 2023
3.5 Newborn and Prenatal Genetic Testing Key Players Head office and Area Served
3.6 Key Players Newborn and Prenatal Genetic Testing Product Solution and Service
3.7 Date of Enter into Newborn and Prenatal Genetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn and Prenatal Genetic Testing Breakdown Data by Type
4.1 Global Newborn and Prenatal Genetic Testing Historic Market Size by Type (2019-2024)
4.2 Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Type (2025-2030)
5 Newborn and Prenatal Genetic Testing Breakdown Data by Application
5.1 Global Newborn and Prenatal Genetic Testing Historic Market Size by Application (2019-2024)
5.2 Global Newborn and Prenatal Genetic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Newborn and Prenatal Genetic Testing Market Size (2019-2030)
6.2 North America Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024)
6.4 North America Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn and Prenatal Genetic Testing Market Size (2019-2030)
7.2 Europe Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024)
7.4 Europe Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn and Prenatal Genetic Testing Market Size (2019-2030)
8.2 Asia-Pacific Newborn and Prenatal Genetic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Newborn and Prenatal Genetic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Newborn and Prenatal Genetic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn and Prenatal Genetic Testing Market Size (2019-2030)
9.2 Latin America Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024)
9.4 Latin America Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn and Prenatal Genetic Testing Market Size (2019-2030)
10.2 Middle East & Africa Newborn and Prenatal Genetic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Newborn and Prenatal Genetic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Newborn and Prenatal Genetic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Perkin Elmer
11.1.1 Perkin Elmer Company Detail
11.1.2 Perkin Elmer Business Overview
11.1.3 Perkin Elmer Newborn and Prenatal Genetic Testing Introduction
11.1.4 Perkin Elmer Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.1.5 Perkin Elmer Recent Development
11.2 Verinata Health
11.2.1 Verinata Health Company Detail
11.2.2 Verinata Health Business Overview
11.2.3 Verinata Health Newborn and Prenatal Genetic Testing Introduction
11.2.4 Verinata Health Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.2.5 Verinata Health Recent Development
11.3 Sequenom, Inc.
11.3.1 Sequenom, Inc. Company Detail
11.3.2 Sequenom, Inc. Business Overview
11.3.3 Sequenom, Inc. Newborn and Prenatal Genetic Testing Introduction
11.3.4 Sequenom, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.3.5 Sequenom, Inc. Recent Development
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Detail
11.4.2 Agilent Technologies, Inc. Business Overview
11.4.3 Agilent Technologies, Inc. Newborn and Prenatal Genetic Testing Introduction
11.4.4 Agilent Technologies, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.4.5 Agilent Technologies, Inc. Recent Development
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Bio-Rad Laboratories, Inc. Company Detail
11.5.2 Bio-Rad Laboratories, Inc. Business Overview
11.5.3 Bio-Rad Laboratories, Inc. Newborn and Prenatal Genetic Testing Introduction
11.5.4 Bio-Rad Laboratories, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.5.5 Bio-Rad Laboratories, Inc. Recent Development
11.6 Natera, Inc.
11.6.1 Natera, Inc. Company Detail
11.6.2 Natera, Inc. Business Overview
11.6.3 Natera, Inc. Newborn and Prenatal Genetic Testing Introduction
11.6.4 Natera, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.6.5 Natera, Inc. Recent Development
11.7 Illumina, Inc.
11.7.1 Illumina, Inc. Company Detail
11.7.2 Illumina, Inc. Business Overview
11.7.3 Illumina, Inc. Newborn and Prenatal Genetic Testing Introduction
11.7.4 Illumina, Inc. Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.7.5 Illumina, Inc. Recent Development
11.8 Ariosa Diagnostics
11.8.1 Ariosa Diagnostics Company Detail
11.8.2 Ariosa Diagnostics Business Overview
11.8.3 Ariosa Diagnostics Newborn and Prenatal Genetic Testing Introduction
11.8.4 Ariosa Diagnostics Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.8.5 Ariosa Diagnostics Recent Development
11.9 BGI
11.9.1 BGI Company Detail
11.9.2 BGI Business Overview
11.9.3 BGI Newborn and Prenatal Genetic Testing Introduction
11.9.4 BGI Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.9.5 BGI Recent Development
11.10 CapitalBio MedLab
11.10.1 CapitalBio MedLab Company Detail
11.10.2 CapitalBio MedLab Business Overview
11.10.3 CapitalBio MedLab Newborn and Prenatal Genetic Testing Introduction
11.10.4 CapitalBio MedLab Revenue in Newborn and Prenatal Genetic Testing Business (2019-2024)
11.10.5 CapitalBio MedLab Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
